3 withdrawn, 2 completed, 2 unknown. 7 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Withdrawn 3, Completed 2, Unknown 2 |
| Phase 2 | 3 | Completed 2, Unknown 1 |
Follow Glycine: new trials by email Literature Review of Glycine trials Research Report on Glycine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Effects of Glycine on Atherosclerosis and Metabolic Syndrome-related Parameters. Glycine - Metabolic Syndrome, Dyslipidemias | Phase 2 / Phase 3 | Unknown | Prof. Tony hayek MD | 50 | 2019-03-01 | 2019-02-21 |
| Long-term Impact and Intervention for Diarrhea in Brazil Glutamine, Vitamin A, glycine - Diarrheal Disorder | Phase 3 | Unknown | University of Virginia | 321 | 2006-06-01 | 2011-03-08 |
| Glycine vs Placebo for the Schizophrenia Prodrome Glycine, Placebo - Schizophrenia Prodrome | Phase 2 / Phase 3 | Completed | Yale University | 8 | 2006-03-01 | 2020-04-02 |
| HIAS II - Study of Nutritional Supplementation in Hospitalized Children With Persistent Diarrhea or Malnutrition Alanyl-glutamine, Glycine - Diarrhea, Malnutrition, Other Nutritional Deficiencies | Phase 3 | Withdrawn | University of Virginia | 108 | 2004-08-01 | 2008-10-28 |
| Clinical Trial of Alanyl-Glutamine or Glycine in Children With Persistent Diarrhea or Malnutrition alanyl-glutamine, glycine - Diarrhea, Malnutrition | Phase 3 | Withdrawn | University of Virginia | 108 | 2004-08-01 | 2008-10-28 |
| Adjunctive Treatment for Decreasing Symptoms of Schizophrenia d-cycloserine, glycine, placebo - Schizophrenia, Schizoaffective Disorder | Phase 2 / Phase 3 | Completed | University of Maryland, Baltimore | 240 | 2000-01-01 | 2019-08-20 |
| Glycine and D-Cycloserine in Schizophrenia D-cycloserine, Glycine, Clozapine - Schizophrenia | Phase 3 | Withdrawn | Massachusetts General Hospital | 1998-03-01 | 2014-06-12 |
Diarrhea (2) · Malnutrition (2) · Schizophrenia (2) · Atherosclerosis (1) · Child Nutrition Disorders (1) · Cognitive Dysfunction (1) · Deficiency Diseases (1) · Diabetes Mellitus (1) · Dyslipidemias (1) · Metabolic Syndrome (1) · Obesity (1) · Psychotic Disorders (1)
University of Virginia (3) · Massachusetts General Hospital (1) · Prof. Tony hayek MD (1) · University of Maryland, Baltimore (1) · Yale University (1)
United States (3) · Brazil (1) · Israel (1)
Richard L Guerrant, MD (2) · Donald Goff, MD (1) · Richard L Guerrrant, MD (1) · Scott W Woods, MD (1) · Tony Hayek, MD (1) · William T Carpenter, MD (1)
PMID 17898352, PMID 20038852, PMID 22249475, PMID 23089076, PMID 23644855, PMID 24714829, PMID 38837034
R01MH059807 (1)